Johnson & Johnson will take control of plant that spoiled COVID-19 vaccine doses

Johnson & Johnson.
(Image credit: Tasos Katopodis/Getty Images)

At the direction of the Department of Health and Human Services, Johnson & Johnson will take charge of the Baltimore contract plant that ruined 15 million doses of its COVID-19 vaccine, senior federal health officials told The New York Times. Johnson & Johnson confirmed the news Saturday night.

The doses were spoiled because of a mistake at a facility run by Emergent BioSolution, a manufacturing partner to both Johnson & Johnson and AstraZeneca, which has also developed a COVID-19 vaccine, albeit one that has yet to be authorized by the Food and Drug Administration. Workers at the plant accidentally mixed up the ingredients of the two shots, delaying future shipments of the Johnson & Johnson vaccine, though reportedly not enough to force Johnson & Johnson to modify its goal of delivering 100 million doses to the U.S. government by the end of May.

Subscribe to The Week

Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

SUBSCRIBE & SAVE
https://cdn.mos.cms.futurecdn.net/flexiimages/jacafc5zvs1692883516.jpg

Sign up for The Week's Free Newsletters

From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.

From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.

Sign up
Explore More
Tim O'Donnell

Tim is a staff writer at The Week and has contributed to Bedford and Bowery and The New York Transatlantic. He is a graduate of Occidental College and NYU's journalism school. Tim enjoys writing about baseball, Europe, and extinct megafauna. He lives in New York City.